Minimising risks in point-of-care testing
By
Molecular point-of-care tests are starting to make a significant impression on the market. Dr Carmelo Volpe, commercial director at Enigma Diagnostics, tells Practical Patient Care about the importance of usability in device design, how best to reduce the risk of cross-contamination and what steps need to be taken before such devices are regularly reimbursed.